Evidence map›Paper›PMID 34497402›Full record

ReviewNature reviews. Cardiology2022

Epidemiology of cardiovascular disease in Europe.

Nick Townsend, Denis Kazakiewicz, F Lucy Wright, Adam Timmis, Radu Huculeci, Aleksandra Torbica, Chris P Gale, Stephan Achenbach, Franz Weidinger, Panos Vardas

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 405 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
405citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06506071 unknown statusnot on this map

Characterization of Acute Myocardial Damage With Spectral Computed Tomography. CADAMI-SPECTRAL.

TypeobservationalSponsorSalamanca University HospitalRan2022 to 2025Enrolled300ConditionsMyocarditis, Acute or Subacute, Takotsubo Cardiomyopathy, Infarction, MyocardialArmsSpectral CT
NCT07086989 recruitingnot on this mapstarted 2025, after this paper: background citation

Cardiovascular Risk in Children With Chronic Conditions Study

TypeobservationalSponsorSemmelweis UniversityRan2025 to 2029Enrolled300ConditionsKidney Transplant, Familial Hypercholesterolaemia, Type 1 Diabetes Mellitus (T1DM), Type 2 Diabetes Mellitus (T2DM)
3 · Its place in the literature

Who cites it

405 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

345 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nick TownsendDepartment for Health, University of Bath, Bath, UK. n.p.townsend@bath.ac.uk.ORCID http://orcid.org/0000-0001-9890-0901
Denis KazakiewiczEuropean Society of Cardiology Health Policy Unit, European Heart Health Institute, Brussels, Belgium.
F Lucy WrightNuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK.
Adam TimmisEuropean Society of Cardiology Health Policy Unit, European Heart Health Institute, Brussels, Belgium.
Radu HuculeciEuropean Society of Cardiology Health Policy Unit, European Heart Health Institute, Brussels, Belgium.ORCID http://orcid.org/0000-0003-0863-4668
Aleksandra TorbicaCentre for Research on Health and Social Care Management (CERGAS), Bocconi University, Milan, Italy.
Chris P GaleLeeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Stephan AchenbachEuropean Society of Cardiology Health Policy Unit, European Heart Health Institute, Brussels, Belgium.
Franz WeidingerEuropean Society of Cardiology Health Policy Unit, European Heart Health Institute, Brussels, Belgium.
Panos VardasEuropean Society of Cardiology Health Policy Unit, European Heart Health Institute, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This Review presents data describing the health burden of cardiovascular disease (CVD) within and across the WHO European Region. CVD remains the most common cause of death in the region. Deaths from CVD in those aged <70 years, commonly referred to as premature, are a particular concern, with >60 million potential years of life lost to CVD in Europe annually. Although more women than men die from CVD, age-standardized rates of both morbidity and death are higher in men, and these differences in rates are greatest in individuals aged <70 years. Large inequalities in all measures of morbidity, treatment and mortality can be found between countries across the continent and must be a focus for improving health. Large differences also exist in the data available between countries. The development and implementation of evidence-based preventive and treatment approaches must be supported in all countries by consistent surveillance and monitoring, such that we can quantify the health burden of CVD as well as target interventions and provide impetus for action across Europe.

Indexed as

Cardiovascular DiseasesAgedEuropeFemaleHumansMaleMorbidity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.